MedPath

Felbamate

Felbamate Oral Suspension USP

Approved
Approval ID

556de35d-3b98-48d3-a670-50e9d93437a4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 17, 2018

Manufacturers
FDA

NORTHSTAR RX LLC

DUNS: 830546433

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Felbamate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16714-775
Application NumberANDA206314
Product Classification
M
Marketing Category
C73584
G
Generic Name
Felbamate
Product Specifications
Route of AdministrationORAL
Effective DateApril 17, 2018
FDA Product Classification

INGREDIENTS (13)

FelbamateActive
Quantity: 600 mg in 5 mL
Code: X72RBB02N8
Classification: ACTIB
citric acid monohydrateInactive
Code: 2968PHW8QP
Classification: IACT
FD&C Yellow No. 6Inactive
Code: H77VEI93A8
Classification: IACT
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORMInactive
Code: K679OBS311
Classification: IACT
FD&C Red No. 40Inactive
Code: WZB9127XOA
Classification: IACT
glycerinInactive
Code: PDC6A3C0OX
Classification: IACT
methylparabenInactive
Code: A2I8C7HI9T
Classification: IACT
polysorbate 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
microcrystalline celluloseInactive
Code: OP1R32D61U
Classification: IACT
propylparabenInactive
Code: Z8IX2SC1OH
Classification: IACT
sorbitolInactive
Code: 506T60A25R
Classification: IACT
sucraloseInactive
Code: 96K6UQ3ZD4
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.